课题基金 / 基金详情

Biomaterials with Rationally Immobilized Growth Factors

Biomaterials with Rationally Immobilized Growth Factors
具有合理固定的生长因子的生物材料
批准号:
7118626
负责人:
DAVID A. PULEO
金额:
$31.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2008-06-30

项目摘要

项目成果

DAVID A. PULEO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Ideally, implants should be designed with the ability to promote specific biological responses. In the case of bone-contacting materials, this would mean that, immediately following implantation, the devices would induce cells of the osteoblastic lineage to form bone on or in close proximity to the biomaterial. Stable fixation of the implant and better integration into the tissue would be the result. The overall goal of this research is to develop biomolecular surface modification strategies that induce specific cell and tissue responses. For example, stimulation of tissue regeneration, in which the implant becomes integrated into the tissue, is more desirable than repair, in which the implant is generally walled off with a fibrous capsule. It is postulated that bone-contacting materials possessing surfaces with osteotropic biomolecules in a specific presentation can control initial cellular events at the tissue-biomaterial interface. In Specific Aim 1, bis-hydrazide-derivatized poly(D,L-lactide-co-glycolide) coatings, microspheres, and porous scaffolds will be developed for use in site-directed immobilization of osteotropic growth factors. Surfaces with different lengths and surface densities of bis-hydrazide molecules will be produced. In Specific Aim 2, rational schemes will be designed and implemented for site-directed immobilization of growth factors on the materials developed in Aim 1. Recombinant DNA techniques will be used to introduce modifications to the amino termini of insulin-like growth factor I and bone morphogenetic protein 2. These unique sites will allow the growth factors to be immobilized in an orientation that maximizes interaction with cell surface receptors. In Specific Aim 3, in vitro and in vivo biological activity of the rationally modified biomaterials will be determined. Cell cultures will also be used to assess activation of the appropriate cell surface receptors by the immobilized growth factors. It is hypothesized that site-directed immobilization of growth factors will yield higher specific bioactivity and, therefore, will result in greater cell and tissue responses (specifically bone formation) compared to randomly immobilized protein. The findings of these studies will impact the development of bone-contacting biomaterials having the ability to induce desired interracial responses.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.cden.2006.03.001
发表时间: 2006-07-01
期刊: Dental clinics of North America
影响因子: --
作者: [Puleo, David A, Thomas, Mark V]
通讯作者: Thomas, Mark V
DOI: 10.1021/bc2003132
发表时间: 2011-12-21
期刊: BIOCONJUGATE CHEMISTRY
影响因子: 4.7
作者: [Yewle, Jivan N., Puleo, David A., Bachas, Leonidas G.]
通讯作者: Bachas, Leonidas G.
DOI: 10.1016/j.actbio.2007.01.003
发表时间: 2007-07
期刊: Acta biomaterialia
影响因子: 9.7
作者: [K. Lee;R. R. Itharaju-R.;D. Puleo]
通讯作者: K. Lee;R. R. Itharaju-R.;D. Puleo
Formulations for intermittent release of parathyroid hormone (1-34) and local enhancement of osteoblast activities.
用于间歇性释放甲状旁腺激素 (1-34) 和局部增强成骨细胞活性的制剂。
DOI: 10.1080/10837450802282488
发表时间: 2008
期刊: Pharmaceutical development and technology
影响因子: 3.4
作者: [Jeon,JH, Puleo,DA]
通讯作者: Puleo,DA
7
    Biodegradable Polymerized Simvastatin
    • 批准号:
      8622285
    • 项目类别:
    • 资助金额:
      $18.63万
    • 财政年份:
      2014
    • 负责人:
      DAVID A. PULEO
    • 依托单位:
    Modulating Inflammation and Fibrosis to Control Scarring in Muscle Wounds
    • 批准号:
      8372021
    • 项目类别:
    • 资助金额:
      $31.34万
    • 财政年份:
      2012
    • 负责人:
      DAVID A. PULEO
    • 依托单位:
    Modulating Inflammation and Fibrosis to Control Scarring in Muscle Wounds
    • 批准号:
      8505378
    • 项目类别:
    • 资助金额:
      $30.32万
    • 财政年份:
      2012
    • 负责人:
      DAVID A. PULEO
    • 依托单位:
    Modulating Inflammation and Fibrosis to Control Scarring in Muscle Wounds
    • 批准号:
      8683763
    • 项目类别:
    • 资助金额:
      $4.34万
    • 财政年份:
      2012
    • 负责人:
      DAVID A. PULEO
    • 依托单位:
    海外基金